Amphetamine and Dextroamphetamine (Adderall) Suspension 1 mg/mL*

in Extemporaneous Formulations for Pediatric, Geriatric, and Special Needs Patients
Editors:
Rita K. Jew
,
Winson Soo-Hoo
,
Sarah C. Erush
, and
Elham Amiri
Restricted access